PARP1 and ovarian carcinoma: Inhibition of PARP has been found to sensitize ovarian cancer cells to chemotherapy because when PARP is inhibited, BER cannot proceed and the SSB causes replication fork collapse when it is met in S phase, resulting in DSB [64, 65], If the DSB cannot be repaired, then the cell dies.